Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
10/09/2008 | US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid |
10/09/2008 | US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide |
10/09/2008 | US20080245233 Method for Inhibiting Fouling in Basic Washing Systems |
10/09/2008 | CA2680407A1 Prophylactic and/or therapeutic agent for hyperlipidemia |
10/08/2008 | EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
10/08/2008 | EP1977645A1 Insecticidal derivates of substituted phenylalkylamines |
10/08/2008 | EP1977644A1 Insecticidal derivatives of substituted benzylamines |
10/08/2008 | EP1976839A2 Compounds and methods for modulating protein trafficking |
10/08/2008 | EP1697316B1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
10/08/2008 | EP1606351A4 Cyanine dye labelling reagents with meso-substitution |
10/08/2008 | EP1485363B1 Cyclic amides |
10/08/2008 | EP1379246B1 Nociceptin analogs |
10/08/2008 | CN101282949A Azole and thiazole derivatives and their use |
10/08/2008 | CN101279954A Chiral oxazoline and synthetic method thereof |
10/07/2008 | US7432383 Intermediates for the hemisynthesis of taxanes and preparation processes therefor |
10/07/2008 | US7432293 Heterocyclic compounds useful as Nurr-1 activators |
10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
10/07/2008 | CA2248143C Process to prepare oxazolidinones |
10/02/2008 | WO2008064217A3 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof |
10/02/2008 | WO2008054233A3 Process for the preparation of docetaxel |
10/02/2008 | WO2008020211A3 Benzimidazole, benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof |
10/02/2008 | WO2007117591A9 Total synthesis of salinosporamide a and analogs thereof |
10/02/2008 | WO2007111864A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
10/02/2008 | US20080242711 Inhibitors of cholesterol ester transfer protein |
10/02/2008 | US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis |
10/02/2008 | DE102007015034A1 Lactam-substituierte Dicarbonsäuren und ihre Verwendung Lactam substituted dicarboxylic acids and their use |
10/01/2008 | EP1975162A1 Oxazolone derivative |
10/01/2008 | EP1973889A2 Cetp inhibitors |
10/01/2008 | CN100422159C Stable polymorph of bifeprunox mesilate |
09/30/2008 | US7429659 Isopropyl-piperazin-1-yl)-(5-piperidin-1-ylmethyl-furan-2-yl)-methanone; 5-(4-Fluoro-piperidin-1-ylmethyl)-furan-2-yl]-(4-isopropyl-piperazin-1-yl)-methanone, fumarate salt; insomnia, attention deficit hyperactivity disorders, learning disorders, cognitive dysfunction, eating disorders, obesity |
09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
09/30/2008 | US7429607 5-HT2B receptor antagonists |
09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
09/25/2008 | US20080234293 Tri-aryl/heteroaromatic cannabinoids and use thereof |
09/25/2008 | US20080233606 Use of raman spectroscopy in enzyme activity assays |
09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
09/24/2008 | EP1971595A2 Cetp inhibitors |
09/24/2008 | EP1971573A2 Processes for preparing intermediate compounds useful for the preparation of ezetimibe |
09/23/2008 | US7427636 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups |
09/23/2008 | CA2378795C High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof |
09/18/2008 | WO2008111473A1 Glucokinase activator |
09/18/2008 | WO2008110698A2 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof |
09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
09/18/2008 | CA2679971A1 Glucokinase activator |
09/18/2008 | CA2677295A1 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof |
09/17/2008 | EP1968955A1 Diaromatic amine derivatives as antioxidants |
09/17/2008 | CN101268060A Thiazolinones and oxazolinones and their use as PTP1B inhibitors |
09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
09/17/2008 | CN101268041A Sulphonamide derivatives |
09/17/2008 | CN100418958C Taxane derivatives and processes for the preparation thereof |
09/17/2008 | CN100418952C Biphenyl derivatives and their use as fungicides |
09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
09/16/2008 | US7425633 (3S,5S)-5-(pyrrolidine-1-carbonyl)-N-((1S,2R)-2-(3-(trifluoromethyl)phenyl)cyclopropyl)pyrrolidine-3-carboxamide; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes |
09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
09/12/2008 | WO2008109727A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
09/12/2008 | WO2008109027A2 Tri-aryl/heteroaroaromatic cannabinoids and use thereof |
09/12/2008 | WO2008108735A1 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease |
09/12/2008 | WO2008106860A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
09/12/2008 | CA2696232A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
09/12/2008 | CA2679944A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
09/12/2008 | CA2679314A1 New compounds |
09/11/2008 | US20080221336 Reacting a heterocyclic or aryl chloride and a sulfonated phenol, treating with dimethylformamide, acetonitrile, and thionyl chloride; (2R)-2,3-Dihydro-1-[[4-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-4-oxazolyl]methoxy]phenyl]sulfonyl]-1H-indole-2-carboxylic acid; dyslipidemia, hyperlipidemia |
09/11/2008 | US20080221182 Anti-cancer and anti-microbial oxazolidinones |
09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
09/11/2008 | US20080217580 Organic Luminescent Element |
09/10/2008 | EP1966176A1 Heterocyclic gaba-b modulators |
09/09/2008 | US7423156 Optionally fused oxazolyl- or thiazolyl-aminophenylbenzoyl(cyclo)alkanoic acid derivatives, e.g., trans-(1R,2R)-2-({3'-fluoro-4'-,[(6-fluoro-1,3-benzothiazol-2-yl)amino]-1,1'-biphenyl-4-yl}carbonyl)cyclopentanecarboxylic acid; diacylglycerol O-acyltransferase type 1 inhibitors |
09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
09/04/2008 | WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
09/04/2008 | WO2008104875A1 Oxazolidinones as cholesterol absorption inhibitors |
09/04/2008 | US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
09/04/2008 | CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
09/03/2008 | EP1963288A1 Substituted oxazole derivatives with an analgesic action |
09/03/2008 | EP1963287A1 Glucocorticoid receptor modulators as antiinflammatory agents |
09/03/2008 | EP1704143B1 Malononitrile compound as pesticides |
09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
09/03/2008 | CN100415727C Chirale oxazole-arylpropionic acid derivatives and their use as PPAR agonists |
09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
09/02/2008 | US7420065 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
09/02/2008 | US7420060 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
09/02/2008 | US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
09/02/2008 | US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
08/28/2008 | WO2008103501A1 Compounds and methods for modulating g protein-coupled receptors |
08/28/2008 | US20080207708 Analgesics; antiinflammatory agents; bone disorders; neurodegenerative diseases |
08/28/2008 | US20080207693 Mitotic Kinesin Inhibitors |
08/28/2008 | DE10333368B4 Oberflächenfunktionalisiertes Trägermaterial, Verfahren zu dessen Herstellung und dessen Verwendungen Surface-functionalised carrier material, process for its preparation and its uses |
08/28/2008 | CA2677706A1 Compounds and methods for modulating g protein-coupled receptors |
08/27/2008 | EP1960374A1 Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
08/27/2008 | EP1960369A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
08/27/2008 | EP1960351A1 Propionamide compounds as antiinflammatory agents |
08/27/2008 | EP1959944A1 A pharmaceutical composition comprising an amide derivative |
08/27/2008 | EP1200390B1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides |
08/27/2008 | CN101253147A Organic compounds |
08/27/2008 | CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same |
08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
08/21/2008 | WO2008098857A1 2-aminooxazolines as taar1 ligands |